Sufficiently long-term treatment with combined growth hormone and gonadotropin-releasing hormone analog can improve adult height in short children with isolated Growth Hormone Deficiency (GHD) and in non-GHD short children

Pediatric Endocrinology Reviews

Volumn 5, Issue 1, 2007, Pages 471-481

  Tanaka, Toshiaki ^a  

^a NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

Author keywords

GH deficiency; GnRH analog; Growth hormone treatment; Non GH deficient short children; Puberty

Indexed keywords

GONADORELIN; GONADORELIN AGONIST; GROWTH HORMONE;

ARTICLE; BODY HEIGHT; DRUG EFFICACY; GROWTH HORMONE DEFICIENCY; HUMAN; PUBERTY; SHORT STATURE; ADULT; ANALOGS AND DERIVATIVES; CHILD; PITUITARY DWARFISM; SEXUAL MATURATION;

ADULT; BODY HEIGHT; CHILD; DWARFISM, PITUITARY; GONADOTROPIN-RELEASING HORMONE; GROWTH HORMONE; HUMANS; SEXUAL MATURATION;

EID: 35148842096     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Price DA, Ranke MB. Final height following growth hormone treatment. In: Progress in Growth Hormone Therapy - 5 years of KIGS. (Eds. Ranke MB, Gunnarsson R), J&J Verlag, Mannheim 1994 pp 129-144
2. Cacciari E, Cicognani A, Pirazzoli P, Zucchini S, Salardi S, Balsamo A, Cassio A, Pasini A, Carlá G, Tassinari D, Gualandi S. Final height of patients treated for isolated GH deficiency: examination of 83 patients. Eur J Endocrinol 1997;137:53-60
3. Blethen SL, Baptista J, Kuntze J, Foley T, La Franchi S, Johanson A. Adult height in growth hormone-deficient children treated with biosynthetic GH. The Genentech Growth Study Group. J Clin Endocrinol Metab 1997;82:418-420
4. August GP, Julius JR, Blethen SL. Adult height in children with growth hormone deficiency who are treated with biosynthetic growth hormone: The National Cooperative Growth Study Experience. Pediatrics 1998;102:512-516
5. Cutfield WS, Lindberg A, Chatelain P, Proce DA, Albertsson-Wikland K, Wilton P, Ranke MB. Final height following growth hormone treatment of idiopathic growth hormone deficiency in KIGS. In: Ranke MB, Wilton P (eds). Growth Hormone Therapy in KIGS - 10 Years Experience. Heidelberg: Johann Ambrosius Barth Verlag; 1999 pp. 93-109
6. Tanaka T, Hanew K, Nishi Y, Tachibana K, Yokoya S, Igarashi Y, Hirano T, Fujita K, Saitoh T, Hizuka N, Shimatsu A, Tanaka H, Tanizawa T, Teramoto A, Fujieda K. Final height of growth hormone (GH)-treated short children registered at the Foundation for Growth Science in Japan: Comparison between the pituitary human GH era and the recombinant human GH era. Clin Pediatr Endocrinol 2001;10:53-62
7. Carel JC, Ecosse E, Nicolino M, Tauber M, Leger J, Cabrol S, Bastié-Sigeac I, Chaussain JL, Coste J. Adult height after long-term recombinant growth hormone treatment for idiopathic isolated growth hormone deficiency: observational follow-up study of the French population-based registry. BMJ 2002;325:70-73
8. Tanaka T, Cohen P, Clayton P, Laron Z, Hintz RL, Sizonenko PC. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 2: Growth hormone treatment in growth hormone deficient children. Growth Hormone & IGF Research 2002;12:323-341
9. Buckler JMH. A Longitudinal Study of Adolescent Growth. London, Springer 1990
10. Tanaka T, Imai T. Pubertal maturation in healthy girls and standardization of menarcheal age. J Jpn Pediatr Soc 2005;109:1232-1242
11. Berkey CS, Dockery DW, Wang X, Wypij D, Ferris Jr. B. Longitudinal height velocity standards for U.S. adolescents. Stat Med 1993;12:403-414
12. Coste J, Ecosse E, Lesage C, Chaussain JL, Carel JC. Evaluation of adolescent statural growth in health and disease: reliability of assessment from height measurement series and development of an automated algorithm. Horm Res 2002;58:105-114
13. Tanae A, Horikawa R, Hibi I, Satoh M, Katsumata N, Tanaka T. A trial to improve final height in non-GHD short children with cyproterone acetate. Clin Endocrinol (Tokyo) 1998;46(suppl 33):13-17
14. Stanhope R, Uruena M, Hindmarch P, Leiper AD, Brook CGD. Management of growth hormone deficiency through puberty. Acta Paediatr Scand 1988;372(suppl):47-52
15. Albertsson-Wikland K. Alm F, Aronsson S, Gustafsson J, Hagenäs L, Häger A, Ivarsson S, Kriström, Marcus C, Moëll C, Nilsson KO, Ritzén M, Tuvewo T, Wastgren U, Westphal O, and Åman J. Effect of growth hormone (GH) during puberty in GH-deficient children: preliminary results from an ongoing randomized trial with different dose regimens. Acta Peadiatr 1999;428(suppl):80-84
16. Mauras N, Attie KM, Reiter EO, Saenger P, Baptista J. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group. J Clin Endocrinol Metab 2000;85;3635-3660
17. Smith E, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N Engl J Med 1994;331:1056-1061
18. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995;80:3689-3696
19. Hibi I, Tanaka T, Tanae A, Kagawa J, Hashimoto N, Yoshizawa A, Shizume K. The influence of gonadal function and the effect of gonadal suppression treatment on final height in growth hormone (GH)-treated GH-deficient children. J Clin Endocrinol Metab 1989;69:221-226
20. Saggese G, Cesaretti G, Andreani G, Carlotti C. Combined treatment with growth hormone and gonadotropin-releasing hormone analogues in children with isolated growth hormone deficiency. Acta Endocrinol 1992;127:307-312
21. Adan L, Souberbielle JC, Zucker JM, Pierre-Kahn A, Kalifa C, Brauner R. Adult height in 24 patients treated for growth hormone deficiency and early puberty. J Clin Endocrinol Metab 1997;82:229-233
22. Cassorla F, Mericq V, Eggers M, Avila A, Garcia C, Fuentes A, Rose SR, Cutler Jr GB. Effects of lutenizing hormone-releasing hormone analog-induced pubertal delay in growth hormone (GH)-deficient children treated with GH: preliminary results. J Clin Endocrinol Metab 1997;82:3989-3992
23. Toublanc JE, Couprie C, Garnier P, Job JC. The effects of treatment combining an agonist of gonadotropin-releasing hormone with growth hormone in pubertal patients with isolated growth hormone deficiency. Acta Endocrinol (Copenh). 1989;120:795-799
24. Kohn B, Julius JR, Blethen SL. Combined use of growth hormone and gonadotropin-releasing hormone analogues: The National Cooperative Growth Study Experience. Pediatrics 1999;104(4 Pt 2):1014-1018
25. Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Katsumata N, Tachibana K, Nose O, Hibi I. When and how to combine growth hormone with a luteinizing hormone releasing hormone analogue. Acta Paediatr 1999;428(Suppl):85-88
26. Mericq MV, Eggers M, Avila A, Cutler Jr GB, Cassorla F. Near final height in pubertal growth hormone (GH)-deficients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. J Clin Endocrinol Metab 2000;85:569-573
27. Saggese G, Federico G, Barsanti S, Fiore L. The effect of administering gonadotropin-releasing hormone agonist with recombinant-human growth hormone (GH) on the final height of girls with isolated growth hormone deficiency: results from a controlled study. J Clin Endocrinol Metab 2001;86:1900-1904
28. Tauber M, Berro B, Delagnes V, Lounis N, Jouret B, Pienkowski C, Oliver I, Rochiccioli P. Can some growth hormone (GH)-deficient children benefit from combined therapy with gonadotropin-releasing hormone analogs and GH? Results of a retrospective study. J Clin Endocrinol Metab 2003;88:1179-1183
29. Reiter E, Lindberg A, Ranke MB, Price DA, Albertsson-Wikland K, Cowell CT, Bakker B. The KIGS experience with the addition of gonadotropin-releasing hormone agonists to growth hormone (GH) treatment of children with idiopathic GH deficiency. Horm Res 2003;60(suppl 1):68-73
30. Tanaka T. Combination treatment of GH and LHRH analog to increase pubertal growth for GHD children who enter puberty with short stature. Clin Pediatr Endocrinol 2005;14(suppl 24):7-16
31. Kauli R, Galatzer A, Kornreich L, Lazar L, Pertzelan A, Laron Z. Adult height of girls with central precocious puberty, untreated versus treated with cyproterone acetate or GnRH analogue. A comparative study with re-evaluation of predictions by the Bayley-Pinneau method. Horm Res 1997;47:54-61
32. Bar A, Linder B, Sobel EH, Saenger P, DiMartino-Nardi J. Bayley-Pinneau method of height prediction in girls with central precocious puberty: correlation with adult height. J Pediatr 1995;126:955-958
33. Tanaka T, Niimi H, Matsuo N, Fujieda K, Tachibana K, Ohyama K, Satoh M, Kugu K. Results of long-term follow-up after treatment of central precocious puberty with leuprorelin acetate: evaluation of effectiveness of treatment and recovery of gonadal function. The TAP-144-SR Japanese Study Group on Central Precocious Puberty. J Clin Endocrinol Metab 2005;90:1371-1376
34. Carel JC. Management of short stature with GnRH agonist and cotreatment with growth hormone: A controversial issue. Mol Cell Endocrinol 2006;254-255:226-233
35. Tanaka T, Satoh M, Tanae A, Hibi I. Bone age maturation during growth promoting and GnRHa treatment in Turner syndrome. Turner Syndrome in a Life-Span Perspective (eds by Albertsson-Wikland K, Ranke M) Elsevier Science BV, Amsterdam 1995; pp 191-200
36. Satoh M, Tanaka T. Bone age at onset of pubertal growth spurt and final height in normal children. Clin Pediatr Endocrinol 1995;4:163-167
37. Satoh M, Tanaka T, Hibi I. Analysis of bone age maturation and growth velocity in isolated growth hormone (GH) deficient boys with and without gonadal suppression therapy and in GH deficient boys with associated gonadotropin deficiency. J Pediatr Endocr Metab 1997;10:615-622
38. Tanaka T, Satoh M, Hibi I. Combined GH and LHRH analog treatment can increase pubertal growth in short children. Clin Pediatr Endocrinol 1997;6(suppl 9):39-44
39. Weise M, Flor A, Barnes KM, Cutler Jr GB, Baron J. Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. J Clin Endocrinol Metab 2004;89:591-597
40. Murata M. Japanese specific bone age standard on the TW2. Clin Pediatr Endocrinol 1993;2(suppl 3):35-41
41. Saggese G, Baroncelloni S, Barsanti S. The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency: Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996;81:3077-3083
42. Salle A, Klein M, Pascal-Vigneron V, Dousset B, Leclere J, Weryha G. Successful pregnancy and birth after sequential cotreatment with growth hormone and gonadotropins in a woman with panhypopituitarism: a new treatment protocol. Fertil Steril 2000;74:1248-1250
43. Shoham Z, Conway GS, Osterqaard H, Lahlou N, Bouchard P, Jacobs HS. Cotreatment with growth hormone for induction of spermatogenesis in patients with hypogonadotropic hypogonadism. Fertil Steril 1992;57:1044-1051
44. Komatsu K, Okamura T, Takada G, Miyashita M, Ohno T, Tanaka T. Analysis of natural growth of children with short stature at prepuberty or at final height. I. Follow-up of healthy children at Akita Prefecture. J Jpn Pedaitr Soc 1997;101:610-616
45. Karlberg J, Albertsson-Wikland K. Growth in full-term small-for-gestational-age infants from birth to final height. Pediatr Res 1995;38:733-739
46. Tanaka T, Fujieda K, Yokoya S, Shimatsu A, Tachibana K, Tanaaka H, Tanizawa T, Teramoto A, Nagai T, Nishi Y, Hasegawa Y, Hanew K, Fujita K, Horikawa R, Takada G, Miyashita M, Ohno T, Komatsu K. No improvement of adult height in non-growth hormone (GH) deficient short children with GH treatment. Clin Pediatr Endocrinol 2006;15:15-21
47. Bernasconi S, Street ME, Volta C, Mazzardo G. Final height in non-growth hormone deficient children treated with growth hormone. Clin Endocrinol (Oxf) 1997;47:261-266
48. Wit J-M. Growth hormone treatment of idiopathic short stature in KIGS. IN: Ranake MB, Wilton P, eds. Growth hormone therapy in KIGS-10 years' experience. Heidelberg 1999; pp. 225-243
49. Leschek EW, Rose SR, Yanovski JA, Troendle JF, Quigley CA, Chipman JJ, Crowe BJ, Ross JL, Cassorla FG, Blum WF, Cutler GB Jr. Baron J. Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2004;89:3138-3139
50. Hintz RL, Attie KM, Baptista J, Roche A. Effect of growth hormone treatment on adult height of children with idiopathic short stature. N Engl J Med 1999;340:502-507
51. McCaughey ES, Mulligan J, Voss LD, Betts PR. Randomized trial of growth hormone in short normal girls. Lancet 1998;351:940-944
52. Wit JM, Rekers-Mombarg LT, Cutler GB, Crowe B, Beck TJ, Roberts K, Gill A, Chaussain JL, Frisch H. Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. J Pediatr 2005;146:45-53
53. Job JC, Toublanc JE, Landier F. Growth of short normal children in puberty treated for 3 years with growth hormone alone or in association with gonadotropin-releasing hormone agonist. Horm Res 1994;41:177-184
54. Balducci R, Toscano V, Mangiantini A, Municchi G, Vaccaro F, Picone S, Di Rito A, Boscherini B. Adult height in short normal adolescent girls treated with gonadotropin-releasing hormone analog and growth hormone. J Clin Endocrinol Metab 1995;80:3596-3600
55. Tanaka T, Satoh M, Yasunaga T, Horikawa R, Tanae A, Hibi I. GH and GnRH analog treatment in children who enter puberty at short stature. J Pediatr Endocrinol Metab 1997;10:623-628
56. Lanes R, Gunczler P. Final height after combined growth hormone and gonadotropin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty. Clin Endocrinol 1998;49:197-202
57. Pasquino AM, Pucarelli I, Roggini M, Segni M. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone. J Clin Endocrinol Metab 2000;85:619-622
58. Kamp GA, Mul D, Waelkens JJJ, Jansen M, Van de Waal HAD, Verhoeven-Wind L, Froelich M, Oostdijk W, Wit JM. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. J Clin Endocrinol Metab 2001;86:2969-2975
59. Quintos JBQ, Vogiatzi MG, Harbison MD, New MI. Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analog therapy to improve the height deficit in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001;86:1511-1517
60. Lin-Su K, Vogiatzi MG, Harbison MD, Macapagal MC, Betensky B, Tansil S, New MI. Treatment with growth hormone and luteinizing hormone releasing hormone analog improves final adult height in children with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2005;90:3318-3325
61. Yanovski JA, Rose SR, Municchi G, Pescovitz OH, Hill SC, Cassorla FG, Cutler GB Jr. Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. N Engl J Med 2003;348:908-917
62. Carel JC, Hay F, Coutant R, Rodrigue D, Chaussain JL. Gonadotropin releasing hormone agonist treatment of girls with constitutional short stature and normal pubertal development. J Clin Endocrinol Metab 1996;81:3318-3322
63. Antoniazzi F, Zamboni G, Bertoldo F, Lauriola S, Tato L. Bone development during GH and GnRH analog. Eur J Endocrinol 2004;151(suppl 1):S47-S54
64. Mericq V, Gajardo H, Eggeres M, Avila A, Cassorla F. Effects of treatment with GH alone or in combination with LHRH analog on bone mineral density in pubertal GH-deficient patients. J Clin Endocrinol Metab 2002;87:84-89
65. Kaplowitz PB. If gonadotropin-releasing hormone plus growth hormone (GH) really improves growth outcomes in short non-GH-deficient children, then what? J Clin Endocrinol Metab 2001;86:2965-2968
66. Wit JM, Balen HV, Kamp GA, Oostdijk W. Benefit of postponing normal puberty for improving final height. Eur J Endocrinol 2004;151(suppl 1):S41-S45